West Pharmaceutical Services Inc WST

Morningstar Rating
$299.81 +0.01 (< 0.01%)
View Full Chart

Company Report

West Pharmaceutical Facing Headwinds in 2024, but Long-Term Growth and Margin Expansion Story Intact

West Pharmaceutical Services is the global market leader in primary packaging and delivery components for injectable therapeutics. Primary packaging has direct contact with the drug product and must be manufactured to ensure stability, purity, and sterility of the drug product in accordance with strict regulatory standards. Because of the mission-critical nature of these components, it is important for customers to trust the quality of manufacturing and design. Key product lines include elastomer components such as stoppers, seals, and plungers, Daikyo Crystal Zenith vials made out of polymer instead of glass, and auto-injectors. Injectables includes not only older modalities like small molecule drugs, insulin, and vaccines but also biologics and GLP-1 obesity drugs.

Price vs Fair Value

WST is trading at a 426% premium.
Price
$299.81
Fair Value
$428.00
Uncertainty
Medium
1-Star Price
$197.10
5-Star Price
$455.40
Economic Moat
Ncq
Capital Allocation
Ypgcdnvx

Bulls Say, Bears Say

Bulls

West’s top-line growth is likely to be buoyed by secular trends in injectable drugs, especially increasing use of biologic drugs.

Bears

Many of West’s products and services could be insourced by customers, and a reversal of higher outsourcing could occur if customers decide they want more control over the supply chain.

News

Trading Information

Previous Close Price
$299.80
Day Range
$297.19303.30
52-Week Range
$265.00413.70
Bid/Ask
$280.00 / $330.00
Market Cap
$21.75 Bil
Volume/Avg
281,767 / 545,099

Key Statistics

Price/Earnings (Normalized)
42.41
Price/Sales
7.77
Dividend Yield (Trailing)
0.27%
Dividend Yield (Forward)
0.27%
Total Yield
3.32%

Company Profile

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
10,600

Competitors

Valuation

Metric
WST
PODD
BDX
Price/Earnings (Normalized)
42.4168.6218.79
Price/Book Value
8.4516.342.68
Price/Sales
7.779.373.53
Price/Cash Flow
31.0044.1419.04
Price/Earnings
WST
PODD
BDX

Financial Strength

Metric
WST
PODD
BDX
Quick Ratio
1.462.411.20
Current Ratio
2.343.601.85
Interest Coverage
81.967.034.20
Quick Ratio
WST
PODD
BDX

Profitability

Metric
WST
PODD
BDX
Return on Assets (Normalized)
14.38%9.03%3.65%
Return on Equity (Normalized)
19.18%31.74%7.60%
Return on Invested Capital (Normalized)
16.67%11.10%5.30%
Return on Assets
WST
PODD
BDX

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
RjxgywmnfJfmq$172.9 Bil
Becton Dickinson & Co
BDX
SxrznnslVnrjbv$69.3 Bil
Alcon Inc
ALC
ThrfhkvSgwgqb$49.2 Bil
ResMed Inc
RMD
PzksdsbyzRkrcvfp$35.1 Bil
Coloplast AS ADR
CLPBY
SkkgddjcnhKqtfj$29.2 Bil
The Cooper Companies Inc
COO
FrgbkcbCqtkdn$21.5 Bil
Hologic Inc
HOLX
LttgflmyNrmqmx$18.5 Bil
Baxter International Inc
BAX
SmbtbrrmJcfqkmj$18.4 Bil
Align Technology Inc
ALGN
PsxpfysWrskdp$17.8 Bil

Sponsor Center